The Role of EphB4 and EphrinB2 in Head and Neck Squamous Cell Carcinoma

QR Code

The Role of EphB4 and EphrinB2 in Head and Neck Squamous Cell Carcinoma

None

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Yavrouian, Eric J., Sinha, Uttam K., Masood, Rizwan
Hōputu:	Tāhiko Wāhanga pukapuka
Reo:	Ingarihi
I whakaputaina:	IntechOpen 2012
Ngā marau:	Health Sciences
Urunga tuihono:	https://www.intechopen.com/chapters/27534
Tags:	Tāpirihia he Tūtohu No Tags, Be the first to tag this record!

Ngā tūemi rite

Overexpression of junctional adhesion molecule-A and EphB2 predicts poor survival in lung adenocarcinoma patients
mā: Chen Zhao, me ētahi atu.
I whakaputaina: (2017-02-01)

Epigenetics in Head and Neck Squamous Cell Carcinoma
mā: Chirila, Magdalena
I whakaputaina: (2012)

Metastasis of Head and Neck Squamous Cell Carcinoma
mā: Li, Xiaoming, me ētahi atu.
I whakaputaina: (2012)

The Cellular Microenvironment of Head and Neck Squamous Cell Carcinoma
mā: Mathew, Maya, me ētahi atu.
I whakaputaina: (2012)

Molecular features of head and neck squamous cell carcinoma
mā: G. V. Kakurina, me ētahi atu.
I whakaputaina: (2018-09-01)

MicroRNA Dysregulation in Squamous Cell Carcinoma of Head and Neck
mā: Wong, Thian-Sze, me ētahi atu.
I whakaputaina: (2012)

Cancer Initiating Cells in Head and Neck Squamous Cell Carcinoma
mā: Paramio, Jesús M.
I whakaputaina: (2011)

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
mā: T. Braunschweig, me ētahi atu.
I whakaputaina: (2015-04-01)

Prospects of epigenetic therapy of head and neck squamous cell carcinoma
mā: R. N. Mustafin
I whakaputaina: (2023-09-01)

EXPRESSION PROFILE OF MICRORNAS IN SQUAMOUS CELL HEAD AND NECK CARCINOMA
mā: Yu. A. Veryaskina, me ētahi atu.
I whakaputaina: (2016-02-01)

Risk Factors and Diagnosis of Head and Neck Squamous Cell Carcinoma
mā: Yussy Afriani Dewi, me ētahi atu.
I whakaputaina: (2024-12-01)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
mā: Muzaffar Shah-Khan, me ētahi atu.
I whakaputaina: (2013-03-01)

Molecular and genetic profile of head and neck squamous cell carcinoma
mā: A. I. Stukan, me ētahi atu.
I whakaputaina: (2018-10-01)

Fanconi Anemia/Brca Pathway and Head and Neck Squamous Cell Carcinomas
mā: Lu, Shi-Long
I whakaputaina: (2011)

Methylation of the tumor associated genes in head and neck squamous cell carcinoma
mā: S. V. Kurevlev, me ētahi atu.
I whakaputaina: (2023-03-01)

Contrast-enhanced ultrasound in the diagnosis of head and neck squamous cell carcinoma
mā: G. F. Allakhverdieva, me ētahi atu.
I whakaputaina: (2019-04-01)

Study of head and neck squamous cell carcinoma transcriptome after proton therapy
mā: E. D. Jumaniyazova, me ētahi atu.
I whakaputaina: (2024-04-01)

OPTIMAL TREATMENT STRATEGY FOR PATIENTS WITH PROGRESSIVE SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
mā: L. V. Bolotina, me ētahi atu.
I whakaputaina: (2019-09-01)

First-line chemotherapy for head and neck squamous cell carcinoma. Optimal strategy
mā: L. V. Bolotina, me ētahi atu.
I whakaputaina: (2019-01-01)

Current trends in the immunotherapy of metastatic and recurrent squamous cell carcinoma of the head and neck
mā: Yu. V. Kostalanova, me ētahi atu.
I whakaputaina: (2020-11-01)

Characteristics of inflammatory reactions in the tumor microenvironment of head and neck squamous cell carcinoma
mā: V. A. Bychkov, me ētahi atu.
I whakaputaina: (2019-01-01)

Role of E-cadherin and β-catenin in head and neck squamous cell carcinoma
mā: A. A. Petrova, me ētahi atu.
I whakaputaina: (2024-01-01)

ASSESSMENT OF BLOOD SERUM PROTEOME IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CARCINOMA
mā: G. V. Kakurina, me ētahi atu.
I whakaputaina: (2016-02-01)

HEAD AND NECK SQUAMOUS CELL CARCINOMA DEPENDING ON THE MORPHOLOGICAL CHARACTERISTICS OF THE PRIMARY TUMOR
mā: V. A. Bychkov, me ētahi atu.
I whakaputaina: (2017-06-01)

Vitamin D3 and Its Role in the Treatment of Head and Neck Squamous Cell Carcinoma
mā: Young, M. Rita I., me ētahi atu.
I whakaputaina: (2012)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
mā: Ye. V. Klisho, me ētahi atu.
I whakaputaina: (2011-02-01)

Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
mā: A. M. Mudunov, me ētahi atu.
I whakaputaina: (2019-04-01)

EPIGENETIC REGULATION OF GENE EXPRESSION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: THERAPEUTIC PERSPECTIVES
mā: R. B. Samsonov, me ētahi atu.
I whakaputaina: (2017-04-01)

and variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients
mā: Ericka Francislaine Dias Costa, me ētahi atu.
I whakaputaina: (2020-07-01)

Effects of educational status and the living environment on the prognosis of head and neck squamous cell carcinoma
mā: Zeynep Oruç, me ētahi atu.
I whakaputaina: (2016-08-01)

Radiodosiomics Prediction of Treatment Failures Prior to Chemoradiotherapy in Head-and-Neck Squamous Cell Carcinoma
mā: Hidemi Kamezawa, me ētahi atu.
I whakaputaina: (2025-06-01)

Molecular Genetics and Biology of Head and Neck Squamous Cell Carcinoma: Implications for Diagnosis, Prognosis and Treatment
mā: Ganci, Federica, me ētahi atu.
I whakaputaina: (2012)

The importance in clinical practice of the signal lymph node biopsy in squamous cell carcinoma of the head and neck
mā: I. M. Gelfand, me ētahi atu.
I whakaputaina: (2024-04-01)

NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
mā: A. M. Mudunov, me ētahi atu.
I whakaputaina: (2017-06-01)

The role of cetuximab in the treatment of patients with squamous cell carcinoma of the head and neck: resolution of the Expert Council
I whakaputaina: (2019-01-01)

An update on head and neck squamous cell carcinoma in respect to classification and systemic therapy. Extended review
mā: A. Mudunov, me ētahi atu.
I whakaputaina: (2018-04-01)

Pembrolizumab in treatment of head and neck squamous cell carcinoma: clinical cases and real-world practice
mā: Yu. V. Alymov, me ētahi atu.
I whakaputaina: (2023-09-01)

Rational sequence of monoclonal antibodies in the treatment of non-resectable head and neck squamous cell carcinoma
mā: L. V. Bolotina, me ētahi atu.
I whakaputaina: (2022-04-01)

Integrating metabolism gene clusters and tumor immune microenvironment in head and neck squamous cell carcinoma
mā: Meina Lian, me ētahi atu.
I whakaputaina: (2025-06-01)

In-silico molecular analysis and blocking of the viral G protein of Nipah virus interacting with ephrin B2 and B3 receptor by using peptide mass fingerprinting
mā: Ayesha Sajjad, me ētahi atu.
I whakaputaina: (2025-06-01)